ArticleLaboratory medicine2026
SARS-CoV-2 humoral immunity is associated with elevated hemoglobin A1c.
Article in Laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionThis prospective study assessed relationships between COVID-19, humoral immunity, and common laboratory test results.
methodsBlood and urine were collected from adults with clinical SARS-CoV-2 test results before August 2021: nucleic acid amplification (NAA) tests and antinucleocapsid protein (αN) serology. Measurements were made of αN and 13 laboratory tests, and results were compared across groups defined by NAA and αN status.
resultsGlycated hemoglobin (HbA1c) and platelet counts were clinically significantly higher among individuals who had COVID-19 than in individuals without evidence of COVID-19. Hemoglobin was more abnormal among patients without evidence of COVID-19. Glycated hemoglobin results were also much higher among patients with prior positive NAA and current or prior positive αN results than in individuals with negative αN results. No other statistically significant associations between NAA or αN and abnormal laboratory results were found. DISCUSSION: Elevated HbA1c results were associated with prior positive NAA findings combined with positive αN results but not with negative αN results. Further investigation into the association of dysregulated glycemic control with humoral immunity to natural infection is warranted, given the well-documented increase in incidence in type 1 and type 2 diabetes following COVID-19. Prior positive NAA results were also associated with a few nonspecific abnormalities of the complete blood cell count.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.